National Infertility Awareness Week: Infertility Uncovered

By CooperGenomics — April 24, 2019

2 min read

National Infertility Awareness Week® (NIAW) is the largest US awareness campaign addressing the public health issue of infertility. Founded in 1989 by RESOLVE: The National Infertility Association, the event aims to continue educating the public about the impact infertility has on millions of Americans; this year’s observance is during the week of April 21st to 27th, 2019, with the theme ‘Infertility Uncovered’.

As a fertility and genomics company, recognizing this event gives us the fantastic opportunity to help raise awareness of the products and services available to help empower families worldwide, from comprehensive reproductive genetic testing, to improve in vitro fertilization outcomes.

When a patient speaks to one of our genetic counselors or undergoes genetic testing, there is typically an underlying fertility issue that has led them to us. Our aim is then to uncover what may prevent an individual or couple from conceiving or carrying a child to term using a varied mix of resources, and support.

We believe strongly in empowering every patient through transparency, and education; this is why several members of the CooperGenomics family attend Advocacy Day, hosted by Resolve and the American Society for Reproductive Medicine (ASRM), where the infertility community comes together in Washington, D.C. to talk to members of Congress. Important issues raised includes increased access to family building options and financial relief.

Overall, one of our main goals is to support and advocate for those impacted by infertility and/or genetic disease. We strive to be encouraging, educational, and transparent so people can play an active role in their family planning journey.

As you consider your own journey, we encourage you to learn more about your fertility health and family building options. It can never be underestimated how much you are your own best advocate!

In honor of this year’s NIAW theme, we’ve put together a list of some reproductive tests that can help provide insight into fertility health. Speak to your doctor today if any of them feel appropriate for you.

Hysterosalpingogram (HSG): An HSG is a special x-ray procedure to evaluate your fallopian tubes and the shape of your uterine cavity. It is often used in an infertility evaluation because it can show if there are blocked fallopian tubes or any abnormalities in the uterus. Other reasons to perform an HSG can include recurrent miscarriages or abnormal vaginal bleeding. It’s estimated that 8 percent to 23 percent of women who have recurrent miscarriages have some type of uterine abnormality.

Diagnostic Laparoscopy: Laparoscopy is a surgical procedure that doctors use to view a woman’s reproductive organs using a laparoscope. This is a thin viewing tube, like a telescope, which is passed through a small incision in the abdomen. This may be recommended when other diagnostic tests have been performed but no clear cause can be determined for your fertility concerns or any abdominal pain you may be experiencing. Diagnostic laparoscopy can help pinpoint the cause of pain in your pelvic and abdominal area and confirm if you have endometriosis. It can also determine if you have pelvic inflammatory disease (PID), examine tissue mass, and confirm if there are blockages in the fallopian tubes.

PGT-A via PGTaiSM  technology platform: Our groundbreaking, first of its kind algorithm harnesses the power of big data, machine learning and artificial intelligence to improve PGT-A analysis, interpretation and reporting. This means we can more accurately identify embryos that will have an increased likelihood of leading to a successful pregnancy.

ERPeakSM endometrial receptivity test: This test offers accurate and reliable detection of the receptivity status of a woman’s endometrium. The Window of Implantation (WOI) is the short time period during which the endometrium is ready to accept an embryo, i.e. is receptive, for implantation. Studies have shown a 51.7 – 63.2% pregnancy rate in patients with recurrent implantation failure (RIF) who have undergone endometrial receptivity testing. This is typically recommended for patients who have experienced recurrent pregnancy loss.

Other great resources to find further information about tests available for male and female infertility include:

And, of course, we encourage you to continue visiting this website. We remain as committed as ever to keeping you informed about your fertility options.